In a recent study published in the Journal PLoS Genetics, researchers investigated how height determined several common clinical traits in adults by comparing associations of those traits with actual- and genetically-predicted-height.
Targeting a protein complex that inhibits lipoprotein lipase with a monoclonal antibody lowers both triglycerides and LDL cholesterol while increasing HDL cholesterol, suggests an early-stage trial.
After many setbacks, the potential for CETP inhibition to significantly improve cholesterol levels and target attainment has been shown with obicetrapib in the ROSE trial.
Researchers have developed a novel app to show how the increased risk for coronary events due to elevated lipoprotein(a) levels can be countered by lowering LDL cholesterol levels to specific targets.
Istanbul, Turkey: B. Catal, E. Genc, M.A. Cacan et al. have found in a study that - Significantly higher TC (total cholestrol) levels in PF (plantar fasciitis) patients in comparison with other.